Article
Compact type II-D Cas9 nucleases for efficient and specific genome editing
2026-08-18
Abstract excerpt
Compact CRISPR nucleases are attractive for therapeutic genome editing because their small coding sequences facilitate delivery by adeno-associated virus. Type II-D Cas9 (Cas9d) enzymes constitute the most compact Cas9 subtype, yet only a few orthologs have demonstrated mammalian genome-editing activity, leaving it unclear whether this activity is general or exceptional. Here, we mined the IMG/M metagenomic databa...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- f22a856b-78a9-5757-8953-4288ab3a9816
- DOI
- 10.64898/2026.08.17.745286
